Skip to main content
. Author manuscript; available in PMC: 2019 Feb 1.
Published in final edited form as: Surgery. 2017 Nov 22;163(2):336–342. doi: 10.1016/j.surg.2017.09.030

Fig. 5. Virus-treated tumor tissue exhibits increased NK staining one week post-injection.

Fig. 5

Both control tumor tissue (A) and tumor tissue from CF189 105 PFU treatment group (B) were stained for presence of NK cells using antibody against CD49b. No NK cells were visualized in the control tumor tissue, but many NK cells were observed in the treatment group following treatment with HRP-linked secondary antibody (arrowheads). Six weeks post-injection, there were similar numbers of NK cells present in both control (C) and virus-treated (D) tumor tissue.